Inactivation of cytochrome P450 2E1 by tert-butylisothiocyanate

Chemical Research in Toxicology

Volumn 11, Issue 10, 1998, Pages 1154-1161

  Kent, Ute M ^a   Roberts, Elizabeth S ^a,c   Chun, Jarin ^a   Hodge, Kimberly ^a   Juncaj, Jenny ^a   Hollenberg, Paul F ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Med Science Research Building III ^*  (United States)

^c USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 NITROPHENOL; ALCOHOL; CYTOCHROME B5; CYTOCHROME P450 ISOENZYME; ISOTHIOCYANIC ACID DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INDUCTION; ENZYME KINETICS; ENZYME SPECIFICITY; HYDROXYLATION; LIVER MICROSOME; MALE; NONHUMAN; RABBIT; RAT;

ANIMALS; CYTOCHROME P-450 CYP2E1; CYTOCHROMES B5; ENZYME INHIBITORS; HUMANS; ISOTHIOCYANATES; KINETICS; MALE; MICROSOMES, LIVER; RABBITS; RATS; RATS, INBRED F344;

EID: 0031741670     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx980130+     Document Type: Article

References (55)

1. Nelson, D. R., Koymans, L., Kamataki, T., Stegeman, J. J., Feyereisen, R., Waxman, D. J., Waterman, M. R., Gotoh, O., Coon, M. J., Estabrook, R. W., Gunsalus, I. C., and Nebert, D. W. (1996) P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetica 6, 1-42.
2. Guengerich, F. P., Kim, D.-H., and Iwasaki, M. (1991) Role of human cytochrome P450 2E1 in the oxidation of many low molecular weight cancer suspects. Chem. Res. Toxicol. 4, 168-179.
3. Koop, D. R. (1992) Oxidative and reductive metabolism by cytochrome P450 2E1. FASEB J. 6, 725-730.
4. Yoo, J. S. H., Guengerich, F. P., and Yang, C. S. (1988) Metabolism of N-nitrosodialkylamines by human liver microsomes. Cancer Res. 48, 1499-1504.
5. Lewis, D. F. V., Bird, M. G., and Parke, D. V. (1997) Molecular modelling of CYP2E1 enzymes from rat, mouse and man: An explanation for species differences in butadiene metabolism and potential carcinogenisity, rationalization of CYP2E1 substrate specificity. Toxicology 118, 93-113.
6. Ronis, M. J. J., Lindros, K. O., and Ingelman-Sundberg, M. (1996) The Cyp 2E subfamily. In Cytochromes P450: Metabolic and Toxicological Aspects (Ioannides, C., Ed.) pp 211-239, CRC Press, New York.
7. Perrot, N., Nalpas, B., Yang, C. S., and Beaune, P. H. (1989) Modulation of cytochrome-P450 isozymes in human liver by ethanol and drug intake. Eur. J. Clin, Invest. 19, 549-555.
8. Koop, D. R., Morgan, E. T., Tarr, G. E., and Coon, M. J. (1982) Purification and characterization of a unique isozyme of cytochrome P450 from liver microsomes of ethanol-treated rabbits. J. Biol. Chem. 257, 8472-8480.
9. Ingelman-Sundberg, M., Johansson, I., Hu, Y., Terelius, Y., Eliasson, E., Clot, P., and Albano, E. (1994) Ethanol-inducible cytochrome P450 2E1: genetic polymorphism, regulation and possible role in the etiology of alcohol-induced liver disease. Alcohol 10, 447-452.
10. Albano, E., Clot, P., Morimoto, M., Tomassi, A., Ingelman-Sundberg, M., and French, S. W. (1996) Role of cytochrome P450 2E1-dependent formation of hydroxyethyl free radical in the development of liver damage in rats intragastrically fed with ethanol. Hepatology 23, 155-163.
11. Yang, C. S., Yoo, J. S. H., Iahizaki, H., and Hong, J. (1990) Cytochrome P450IIE1: Roles in nitrosamine metabolism and mechanism of regulation. Drug Metab. Rev. 22, 147-159.
12. Villard, P. H., Seree, E., Lacarelle, B., Therene-Fenoglio, M. C., Barra, Y., Altolini, L., Bruguerole, B., Durand, A., and Catalin, J. (1994) Effect of cigarette smoke on hepatic and pulmonary cytochrome P450 in mouse: evidence for CYP2E1 induction in lung. Biochem. Biophys. Res. Commun. 202, 1731-1737.
13. Yamazaki, H., Inui, Y., Yun, C., Guengerich, F. P., and Shimada, T. (1992) Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes. Carcinogenesis 13, 1789-1794.
14. Hoffmann, D., and Hecht, S. S. (1985) Nicotine-derived N-nitrosamines and tobacco related cancer, current status and future directions. Cancer Res. 45, 935-944.
15. Hecht, S. S., and Hoffmann, D. (1988) Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis 9, 875-884.
16. Hoffmann, D., Riverson, A., Abbi, R., and Wynder, E. (1993) A study of tobacco carcinogenesis: effect of the fat content of the diet on the carcinogenic activity of 4-(methylnitroeamino)-1-(3-pyridyl)-1-butane in F344 rats. Cancer Res. 53, 2758-2761.
17. Riverson, A., Hoffmann, D., Prokopczyk, B., Amin, S., and Hecht, S. S. (1988) Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific Areca-derived N-nitrosamine. Cancer Res. 48, 6912-6917.
18. Carmella, S. G., Kagan, S. S., Kagan, M., Foiles, P. G., Palladino, G., Quart, A. M., Quart, E., and Hecht, S. S. (1990) Mass spectrometric analysis of tobacco-specific nitrosamine hemoglobin adducts in snuff dippers, smokers, and non-smokers. Cancer Res. 50, 5438-5445.
19. Foiles, P. G., Akerkar, S. A., Carmella, S. G., Kagan, M., Stoner, G. D., Resau, J. H., and Hecht, S. S. (1991) Mass spectrometric analysis of tobacco-specific nitrosamine-DNA adducts in smokers and nonsmokers. Chem. Res. Toxicol. 4, 364-368.
20. Carmella, S. G., Akerkar, S., and Hecht, S. S. (1993) Metabolites of tobacco-specific nitrosamine 4-(methylnitrosamine)-1-(3-pyridyl)-1-butanone in smokers' urine. Cancer Res. 53, 721-724.
21. Wattenberg, L. (1985) Chemoprevention of cancer. Cancer Res. 45, 1-8.
22. Zhang, Y., and Talalay, P. (1994) Anticarcinogenic activities of organic isothiocyanates: Chemistry and Mechanism. Cancer Res. 54(Suppl.), 1976s-1981s.
23. Wattenberg, L. W. (1978) Inhibition of carcinogenic effects of polycyclic hydrocarbons by benzylisothiocyanate and related compounds. J. Natl. Cancer Inst. 58, 395-398.
24. Stoner, G. D., Morrissey, D. T., Heur, Y. H., Daniel, E. M., Galati, A. J., and Wagner, S. A. (1991) Inhibitory effects of phenethylisothiocyanate on N-nitrosobenzylmethylamine carcinogenesis in rat esophagus. Cancer Res. 51, 2063-2068.
25. Morse, M. A., Wang, C.-X., Stoner, G. D., Mandal, S., Conran, P. B., Amin, S. G., Hecht, S. S., and Chung, F.-L. (1989) Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced DNA adduct formation and tumorige ni city in lung of F344 rats by dietary phenethylisothiocyanate. Cancer Res. 49, 549-553.
26. Hecht, S. S. (1995) Chemopreventioin by isothiocyanates. J. Cell. Biochem. 22 (Suppl.), 195-209.
27. Jiao, D., Conaway, C. C., Wang, M.-H., Yang, C. S., Koehl, W., and Chung F.-L. (1996) Inhibiton of N-nitrosodimethylamine demethylase in rat and human liver microsomes by isothiocyanates and their glutathione, L-cysteine, and N-acetyl-L-cysteine conjugates. Chem. Res. Toxicol. 9, 932-938.
28. Hanna, I. H., Teiber, J. F., Kokones, K. L., and Hollenberg, P. F. (1998) Role of alanine at position 363 of cytochrome P450 2B2 in influencing the NADPH- and hydroperoxide-supported activites. Arch. Biochem. Biophys. 350, 324-332.
29. 2-terminal segment retains catalytic activity and is membrane-bound when expressed in Escherichia coli. J. Biol. Chem. 266, 7321-7324.
30. Saito, T., and Strobel, H. W. (1981) Purification to homogeneity and characterization of a form of cytochrome P450 with high specificity for benzopyrene from β-naphthoflavone-pretreated rat liver microsomes. J. Biol. Chem. 256, 984-988.
31. Koop, D. R. (1986) Hydroxylation of p-nitrophenol by rabbit ethanol-inducible P-450 iaozyme 3a. Mol. Pharmacol. 29, 399-404.
32. Burke, M. D., Thompson, S., Weaver, R. J., Wolf, C. R., and Mayer, R. T. (1994) Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver. Biochem. Pharmacol. 48, 923-936.
33. Ullrich, V., and Weber, P. (1972) The O-dealkylation of 7-ethoxycoumarin by liver microsomes. A direct fluorometic test. Hoppe-Seyler's Z. Physiol. Chem, 353, 1171-1177.
34. Nash, T. (1953) The colorimetic estimation of formaldehyde by means of the Hantzsch reaction. Biochem. J. 55, 416-421.
35. Nerurkar, P. V., Park, S. S., Thomas, P. E., Nims, R. W., and Lubet, R. A. (1993) Methoxyresorufm and benzyloxyresorufin: substrates preferentially metabolized by cytochromes P450 1A2 and 2B, respectively, in rat and mouse. Biochem. Pharmacol. 46, 933-943.
36. Buters, J. T., Schiller, C. D., and Chou, R. C. (1993) A highly sensitive tool for the assay of cytochrome P450 enzyme activity in rat, dog and man. Biochem. Pharmacol. 46, 1577-1584.
37. Kent, U. M., Bend, J. R., Chamberlin, B. A., Gage, D. A., and Hollenberg, P. F. (1997) Mechanism-based inactivation of cytochrome P450 2B1 by N-benzyl-1-aminobenzotriazole. Chem. Res. Toxicol, 10, 600-608.
38. de Andrade, J. B., Bispo, M. S., Rebouças, M. V., Lúcia, M., Carvalho S. M., and Pinheiro, H. L. (1996) Spectrofluorometric determination of formaldehyde in liquid samples. Am. Lab. (Shelton, Conn.) 29 (16), 56-58.
39. Mishin, V. M., Koivisto, T., and Lieber, C. S. (1996) The determination of cytochrome P450 2E1-dependent p-nitrophenol hydroxylation by high-performance liquid chromatography with electrochemical detection. Anal. Biochem. 233, 212-215.
40. Omura, T., and Sato, R. (1964) The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemo protein nature. J. Biol. Chem. 239, 2370-2378.
41. Roberts, E. S., Alworth, W. L., and Hollenberg, P. F. (1998) Mechanism-based inactivation of cytochromes P450 2E1 and 2B1 by 5-phenyl-1-pentyne. Arch. Biochem. Biophys. 354, 295-302.
42. Fenwick, G. R., Heany, R. K., and Mullin, W. J. (1983) Glucosinolates and their breakdown products in food and food plants. Crit. Rev. Food Sci. Nutr. 18, 123-201.
43. Gerber, N. C., and Sligar, S. G. (1994) A role for Asp-251 in cytochrome P-450 cam oxygen activation. J. Biol. Chem. 269, 4260-4286.
44. Roberts, E. S., Pemecky, S. J., Alworth, W. L., and Hollenberg, P. F. (1996) A role for threonine 302 in the mechanism-based inactivation of P450 2B4 by 2-ethynylnaphthalene. Arch. Biochem. Biophys. 331, 170-176.
45. Gillam, E. M. J., Guo, Z., and Guengerich, F. P. (1994) Expression of modified human cytochrome P450 2E1 in Escherichia coli, purification and spectral and catalytic properties. Arch. Biochem. Biophys. 312, 59-66.
46. Yamazaki, H., Nakano, M., Gillam, E. M., Bell, L. C., Guengerich, F. P., and Shimada, T. (1996) Requirements for cytochrome b5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomes. Biochem. Pharmacol. 52, 301-309.
47. Zerilli, A., Ratanasavanh, D., Lucas, D., Goasduft, T., Dreanao, Y., Menara, C., Picart, D., and Berthou, F. (1997) Both cytochromes P450 2E1 and 3A are involved in the O-hydroxylation of p-nitrophenol, a catalytic activity known to be specific for P450 2E1. Chem. Res. Toxicol. 10, 1205-1212.
48. Brady, J. F., Ishizaki, H., Fukuto, J. M., Lin, M. C., Fadel, A., Gapac, J. M., and Yang, C. S. (1991) Inhibition of cytochrome P450 2E1 by diallyl sulfide and its metabolites. Chem. Res, Toxicol. 4, 642-647.
49. Gebhardt, A. C., Lucas, D., Menez, J.-F., and Seitz, H. (1997) Chlormethiazole inhibition of cytochrome P450 2E1 as assessed by chlorzoxazone hydroxylation in humans. Hepatology 26, 957-961.
50. Ishizaki, H., Brady, J. F., Ning, S. M., and Yang, C. S. (1990) Effect of phenethyl isothiocyanate on the microsomal N-nitrosodimethylamine metabolism and other microsomal activities. Xenobiotica 20, 255-264.
51. Yang, C. S., Smith, T. J., and Hong, J.-Y. (1994) Cytochrome P450 enzymes as targets for chemoprevention against chemical carcinogenesis and toxicity: opportunities and limitations. Cancer Res. 54 (Suppl.), 1982s-1986s.
52. Conaway, C. C., Jiao, D., and Chung, F.-L. (1996) Inhibition of rat liver cytochrome P450 isozymes by isothiocyanates and their conjugates: a structure-activity relationship study. Carcinogenesis 17, 2423-2427.
53. Smith, T. J., Guo, Z., Guengerich, P. F., and Yang, C. S. (1996) Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-l-butanone (NNK) by human cytochrome P450 1A2 and its inhibition by phenethyl isothiocyanate. Carcinogenesis 17, 809-813.
54. Guengerich, F. P., Shimada, T., Yun, C.-H., Yamazaki, H., Raney, K. D., Thier, R., Coles, B., and Harris, T. M. (1994) Interactions of ingested food, beverage, and tobacco components involving human cytochrome P450 1A2, 2A6, 2E1, and 3A4 enzymes. Environ. Health Perspect. 102 (Suppl. 9), 49-53.
55. Ortiz de Montellano, P. R., and Correia, M. A. (1995) Inhibition of cytochrome P450 enzymes. In Cytochrome P450: Structure, Mechanism, and Biochemistry (Ortiz de Montellano, P. R., Ed.) pp 305-364, Plenum Press, New York.